FULCRUM THERAPEUTICS, INC.
Balance Sheet
| Line Item | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $48.5M | $50.3M | $197.5M | $47.1M | $42.6M | $42.2M | $58.2M | $72.6M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $322.9M | $338.7M | $357.5M | $205.9M | $219.4M | $232.6M | $249.9M | $267.5M |
| Property, Plant & Equipment | $0 | $2.5M | $2.8M | $3.2M | $3.3M | $3.5M | $3.9M | $4.2M |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $324.0M | $346.8M | $366.3M | $214.9M | $228.8M | $242.6M | $260.7M | $279.0M |
| Liabilities | ||||||||
| Accounts Payable | $3.4M | $2.5M | $1.6M | $2.9M | $1.8M | $1.5M | $1.2M | $4.0M |
| Total Current Liabilities | $10.3M | $9.9M | $13.0M | $11.6M | $9.0M | $8.1M | $11.0M | $14.5M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $13.3M | $13.5M | $17.3M | $16.5M | $14.5M | $14.2M | $17.7M | $21.7M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-639.3M | $-613.2M | $-594.3M | $-573.9M | $-554.3M | $-537.1M | $-519.4M | $-502.8M |
| Total Stockholders' Equity | $310.7M | $333.3M | $349.0M | $198.4M | $214.4M | $228.5M | $243.0M | $257.3M |